Characterization of cell lines derived from breast cancers and normal mammary tissues for the study of the intrinsic molecular subtypesAleix Prat, Charles M. Perou, Olga Karginova et al.|Breast Cancer Research and Treatment|2013Cited by 203
HER2-Enriched Subtype and ERBB2 Expression in HER2-Positive Breast Cancer Treated with Dual HER2 BlockadeAleix Prat, Mothaffar F. Rimawi, Ian E. Krop et al.|JNCI Journal of the National Cancer Institute|2019Cited by 168
Predicting response and survival in chemotherapy-treated triple-negative breast cancerAleix Prat, Emilio Alba, Aňa Lluch et al.|British Journal of Cancer|2014Cited by 113
A multivariable prognostic score to guide systemic therapy in early-stage HER2-positive breast cancer: a retrospective study with an external evaluationAleix Prat, PierFranco Conte, Valentina Guarneri et al.|The Lancet Oncology|2020Cited by 75
Genomic Analyses across Six Cancer Types Identify Basal-like Breast Cancer as a Unique Molecular EntityAleix Prat, Javier Cortés, Bárbara Adamo et al.|Scientific Reports|2013Cited by 56